We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLN
3751
Silence Therapeutics
SLN
$712M
-184
Closed -$4K
FTH
3752
Faeth Therapeutics
FTH
$756M
-640
Closed -$74K
SOHU
3753
Sohu.com
SOHU
$372M
-58,367
Closed -$950K
SOS
3754
SOS Limited
SOS
$14.2M
-140
Closed -$86K
SPXC icon
3755
SPX Corp
SPXC
$10.7B
-71,705
Closed -$4.28M
SPY icon
3756
State Street SPDR S&P 500 ETF Trust
SPY
$810B
-3,773
Closed -$1.79M
SRCE icon
3757
1st Source
SRCE
$2.1B
-5,626
Closed -$279K
NSLR
3758
Neostellar Capital Corp
NSLR
$270M
-16,220
Closed -$210K
STRA icon
3759
Strategic Education
STRA
$1.87B
-14,062
Closed -$813K
SWTX
3760
DELISTED
SpringWorks Therapeutics
SWTX
-10,370
Closed -$643K
TBBK icon
3761
The Bancorp
TBBK
$2.81B
-101,377
Closed -$2.57M
TBI
3762
Trueblue
TBI
$318M
-6,458
Closed -$179K
TEF
3763
DELISTED
Telefonica
TEF
-14,126
Closed -$58K
TEO icon
3764
Telecom Argentina
TEO
$6.13B
-35,765
Closed -$182K
TGNA
3765
DELISTED
TEGNA Inc
TGNA
-66,412
Closed -$1.23M
TIGR
3766
UP Fintech Holding
TIGR
$867M
-117,872
Closed -$579K
TILE icon
3767
Interface
TILE
$2.18B
-25,122
Closed -$401K
TKC icon
3768
Turkcell
TKC
$4.79B
-104,721
Closed -$376K
TLRY icon
3769
Tilray
TLRY
$598M
-102,688
Closed -$7.22M
TLSI icon
3770
TriSalus Life Sciences
TLSI
$331M
-146
Closed -$1K
TLYS icon
3771
Tilly's
TLYS
$133M
-122,280
Closed -$1.97M
TMHC
3772
DELISTED
Taylor Morrison
TMHC
-21,845
Closed -$764K
TMQ
3773
Trilogy Metals
TMQ
$674M
-14,443
Closed -$24K
TNXP icon
3774
Tonix Pharmaceuticals
TNXP
$203M
0
-$3K
TOON icon
3775
Kartoon Studios
TOON
$35.3M
-1,227
Closed -$13K

Similar funds

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.